Výsledky vyhledávání - "Models in vitro"

Biological effects of Micro and Nanoplastics from environmentally relevant sources on an in vitro model of the intestinal barrier

Autoři: Banaei, Gooya

Thesis Advisors: Garcia Rodriguez, Alba, Hernández Bonilla, Alba

Zdroj: TDX (Tesis Doctorals en Xarxa)

Témata: Nanoplàstics, Nanoplastics, Nanoplásticos, Models in vitro, In vitro models, Modelos in vitro, Nanotoxicitat, Nanotoxicity, Nanotoxicidad, Ciències de la Salut

Popis souboru: application/pdf

Přístupová URL adresa: http://hdl.handle.net/10803/695979

The applicability of in vitro models of the intestinal barrier for the risk assessment of engineered nanomaterials used as food additives

Autoři: Garcia Rodriguez, Alba

Přispěvatelé: University/Department: Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia

Thesis Advisors: Marcos Dauder, Ricardo, Cortes Crignola, Constanza

Zdroj: TDX (Tesis Doctorals en Xarxa)

Témata: Nanotoxicologia, Nanotoxicología, Nanotoxicology, Barrera intestinal, Intestinal barrier, Models in vitro, Modelos in vitro, In vitro models, Ciències Experimentals

Popis souboru: application/pdf

Přístupová URL adresa: http://hdl.handle.net/10803/669883

Identificación de biomarcadores en el ictus hemorrágico y su estudio funcional en modelos experimentales

Autoři: Merino Zamorano, Cristina

Přispěvatelé: University/Department: Universitat Autònoma de Barcelona. Departament de Medicina

Thesis Advisors: Hernández Guillamon, Mar, Montaner Villalonga, Joan, Rodríguez Álvarez, José

Zdroj: TDX (Tesis Doctorals en Xarxa)

Témata: Hemorràgia intracerebral, Hemorragia intracerebral, Intracerebrail hemorrhage, Barrera-hematoencefàlica, Barrera hematoencefálica, Bllod-brain barrier, Models in vitro, Modelos in vitro, In vitro models, Ciències de la Salut

Popis souboru: application/pdf

Přístupová URL adresa: http://hdl.handle.net/10803/385211

Formulation And Evaluation of Floating Tablets of Acetazolamide

Autoři: Femina Aranha*, Anusha

Témata: Acetazolamide, floating drug delivery, In-vitro release, kinetic models, In-vitro buoyancy

Nipah Virus (NiV) Treatment via the ψ–Hamzah Model

Autoři: JALALI, SEYED RASOUL

Témata: Nipah virus, NiV, ψ–Hamzah model, Hamzah Equation, zoonotic virus, emerging infectious diseases, neurotropic virus, encephalitis, respiratory failure, neurological impairment, zoonosis, bat-borne virus, fruit bat transmission, pig host, human-to-human transmission, pandemic potential, outbreak modeling, high mortality virus, CNS infection, blood-brain barrier, neural invasion, classical SIR model, SEIR model, epidemiological modeling, disease dynamics, fractal modeling, fractional calculus, fractional derivatives, Caputo derivative, Riemann–Liouville derivative, fractal brain geometry, neuronal fractals, fractal diffusion, hysteresis, immune memory, immune oscillations, microglial activation, brain immune system, neural oscillations, semi-spiral viral migration, non-linear viral dynamics, stochastic behavior, RNA mutation, viral phase shifts, drug resistance, vaccine resistance, Remdesivir, antiviral limitations, nanoparticle penetration, nanomedicine, nanotherapy, vaccine design, drug development, mRNA vaccine, lipid nanoparticles, LNP, PEGylated lipids, vaccine adjuvants, fractal adjuvants, ψ–Hamzah adjuvant, CpG oligonucleotides, immune modulation, microglia activation, targeted immunity, adaptive immunity, innate immunity, 5-year immunity, virus elimination, 99.99% efficacy, oral drug formulation, injectable drug formulation, nanoparticle drug carriers, BBB penetration, antiviral drug molecules, ψ fractal molecules, quantum molecular alteration, receptor blocking, cellular immunity, systemic immunity, pharmacokinetics, pharmacodynamics, ADME simulation, absorption modeling, drug distribution, drug metabolism, drug elimination, Runge–Kutta solver, Grünwald–Letnikov method, numerical simulation, computational virology, mathematical biology, systems biology, fractional-fractal medicine, complex integration, oscillatory equations, phase-breaking effects, virus simulation, epidemiological simulation, CNS modeling, brain infection modeling, therapeutic modeling, vaccine simulation, drug simulation, population modeling, mortality modeling, WHO guidelines, FDA approval, EMA regulation, orphan disease designation, vaccine manufacturing, IVT synthesis, mRNA synthesis, LNP encapsulation, nanoparticle formulation, nano-catalysts, platinum catalysts, gold nanoparticles, fractal molecules, fractal stability, autoclave sterilization, bioreactor conditions, sterile environment, FTIR spectroscopy, TEM microscopy, mass spectrometry, ELISA assays, neutralization assays, preclinical testing, animal models, pig models, macaque models, mouse models, in vitro assays, in vivo testing, vaccine efficacy, drug efficacy, zero systemic toxicity, low side effects, inflammation-free therapy, immunotoxicity testing, biosafety validation, quantum-biological pathways, synthetic biology, advanced biotechnology, precision medicine, personalized medicine, adaptive therapy, smart therapeutics, systemic antiviral therapy, integrative therapy, regenerative immunology, pandemic prevention, outbreak containment, viral eradication, vaccine platforms, antiviral platforms, advanced drug delivery, oral capsule, intramuscular injection, intravenous injection, biopolymer scaffolds, exosome-based delivery, nano-EV delivery, molecular docking, protein-protein interaction, viral glycoprotein G, viral fusion protein F, receptor inhibition, ephrin-B2 receptor, ephrin-B3 receptor, neuronal infection, olfactory epithelium, olfactory bulb, forebrain invasion, brainstem invasion, spinal cord invasion, viral latency, viral reactivation, cytokine storm, cytokine regulation, inflammatory pathways, viral pathogenesis, virology research, epidemic forecasting, epidemic prediction, public health modeling, outbreak response, global health emergency, WHO response, FDA response, mathematical epidemiology, fractional epidemiology, clinical pharmacology, molecular pharmacology, drug repurposing, antiviral repurposing, personalized dosing, immune optimization, health policy, epidemic preparedness, healthcare systems, public health intervention, virology journals, Nature Medicine, NEJM, Science, Cell, JAMA, ClinicalTrials.gov, intellectual property, Seyed Rasoul Jalali, ψ–Hamzah intellectual rights, biomedical simulation, drug storage, vaccine storage, cold chain, lyophilization, freeze-drying, stability testing, drug half-life, zeta potential, nanoparticle size distribution, polydispersity index, cleanroom synthesis, ISO standards, pharmaceutical manufacturing, quality control, biosafety level, virus containment labs, BSL-4, nanoscience, computational immunology, therapeutic vaccines, experimental medicine, translational research, future medicine, universal therapeutic platform, neuroinvasive virus treatment, post-quantum medicine, next-generation virology, global biosecurity

Effective Treatment of Drug-Resistant Cancers (Pancreatic, Glioblastoma, Metastatic) — Vaccine and Drug Development through the Hamzah Model

Autoři: JALALI, SEYED RASOUL

Témata: cancer, oncology, drug resistance, multidrug resistance, tumour heterogeneity, pancreatic cancer, glioblastoma, metastatic cancer, resistant tumours, adaptive resistance, tumour relapse, chemotherapy, radiotherapy, immunotherapy, targeted therapy, nanomedicine, nanotechnology, nanoparticle drug delivery, liposomal delivery, lipid nanoparticles, PLGA nanoparticles, PEGylated nanoparticles, controlled release, targeted release, tumour microenvironment, hypoxia, angiogenesis, vascularisation, tumour stem cells, immune evasion, T–cell activation, CTL response, Th1 induction, immune checkpoint inhibition, PD–1, PD–L1, CTLA–4, CAR–T therapy, NK cells, macrophages, dendritic cells, adaptive immunity, innate immunity, cytokines, interleukins, interferons, chemokines, tumour–associated macrophages, tumour infiltrating lymphocytes, tumour–associated fibroblasts, stromal interactions, tumour signalling, EGFR resistance, PI3K/AKT pathway, MAPK pathway, mTOR signalling, tyrosine kinase inhibition, DNA repair mechanisms, homologous recombination, non–homologous end joining, mismatch repair, DNA repair overdrive, genomic instability, chromosomal instability, mutational landscape, oncogenic mutations, tumour suppressor loss, TP53, BRCA1, BRCA2, KRAS, NRAS, BRAF, EGFR mutations, HER2 amplification, MYC activation, cell cycle dysregulation, apoptosis evasion, senescence bypass, autophagy regulation, metabolic rewiring, Warburg effect, glycolysis, oxidative phosphorylation, mitochondrial dysfunction, lactate export, pH regulation, proton transporters, ion channels, tumour acidity, ROS signalling, redox balance, antioxidant defences, glutathione, thioredoxin, peroxiredoxin, ferroptosis, necroptosis, pyroptosis, cell death pathways, fractional calculus, fractal derivatives, fractional order models, complex integration, multiscale integration, matter–energy transformation, quantum biology, quantum noise, stochastic modelling, chaos theory, bifurcation analysis, attractors, strange attractors, phase transitions, metastability, dynamic equilibrium, complex adaptive systems, systems biology, integrative modelling, computational oncology, mathematical oncology, bioinformatics, omics integration, genomics, transcriptomics, proteomics, metabolomics, epigenomics, pharmacogenomics, pharmacokinetics, pharmacodynamics, PK–PD modelling, absorption, distribution, metabolism, excretion, clearance, plasma volume, bioavailability, half–life, dose–response, EC50, IC50, Emax, Hill coefficient, drug synergy, drug antagonism, combination therapy, polytherapy, cocktail therapy, adaptive dosing, dose escalation, therapeutic window, therapeutic index, off–target effects, side effect minimisation, toxicity reduction, safety margin, quality of life, survival rate, progression–free survival, overall survival, relapse–free survival, clinical trials, preclinical trials, in vivo models, in vitro models, xenografts, organoids, patient–derived xenografts, spheroids, co–culture systems, 3D models, microfluidics, lab–on–chip, organ–on–chip, bioreactors, lyophilisation, freeze drying, nanofabrication, nanocarriers, smart nanoparticles, responsive nanoparticles, stimuli–responsive release, pH–sensitive release, temperature–sensitive release, redox–sensitive release, enzyme–sensitive release, targeted ligands, antibodies, aptamers, peptides, folate targeting, transferrin targeting, EGFR targeting, HER2 targeting, integrins, RGD peptides, nuclear localisation, mitochondrial targeting, lysosomal escape, endosomal release, exosomes, extracellular vesicles, vesicular trafficking, clathrin mediated endocytosis, caveolin mediated endocytosis, macropinocytosis, receptor mediated endocytosis, intracellular trafficking, pharmacological modelling, biophysics, thermodynamics, statistical mechanics, entropy, enthalpy, free energy, Gibbs free energy, Helmholtz free energy, partition functions, state transitions, molecular dynamics, Monte Carlo simulations, lattice models, Ising model, spin systems, neural networks, deep learning, convolutional neural networks, recurrent neural networks, reinforcement learning, generative adversarial networks, variational autoencoders, XGBoost, random forest, decision trees, ensemble learning, predictive modelling, classification, regression, clustering, dimensionality reduction, PCA, t–SNE, UMAP, feature engineering, feature selection, biomarkers, predictive biomarkers, prognostic biomarkers, diagnostic biomarkers, liquid biopsy, circulating tumour DNA, circulating tumour cells, exosomal RNA, tumour markers, CA19–9, CEA, AFP, PSA, CA125, imaging biomarkers, radiomics, PET imaging, MRI, CT imaging, functional imaging, diffusion weighted imaging, perfusion imaging, metabolic imaging, nuclear imaging, image–guided therapy, image processing, signal processing, time series analysis, Fourier analysis, Laplace transforms, fractional Laplacian, differential equations, partial differential equations, integro–differential equations, fractional differential equations, boundary conditions, initial conditions, stability criteria, numerical analysis, discretisation, finite element analysis, spectral methods, operator theory, eigenvalues, eigenvectors, Hilbert space, Banach space, functional analysis, operator semigroups, semigroup theory, stochastic differential equations, Ito calculus, Stratonovich calculus, Langevin dynamics, Fokker–Planck equation, Kolmogorov equations, path integrals, quantum field theory, string theory, cosmological models, general relativity, special relativity, spacetime curvature, energy density, dark matter, dark energy, entropy flow, holographic principle, quantum entanglement, decoherence, superposition, wavefunction collapse, Schrödinger equation, Dirac equation, Heisenberg uncertainty, Planck constant, Boltzmann constant, Avogadro constant, dimensional analysis, scaling laws, renormalisation group, universality, critical phenomena, nonlinearity, nonlocality, long–range interactions, fractional Brownian motion, Lévy flights, anomalous diffusion, subdiffusion, superdiffusion, percolation theory, fractal geometry, Hausdorff dimension, Minkowski dimension, Cantor sets, Sierpinski structures, Koch curve, fractal networks, scale–free networks, small–world networks, network theory, graph theory, adjacency matrices, Laplacian matrices, spectral graph theory, network robustness, percolation threshold, epidemics on networks, cancer networks, signalling networks, metabolic networks, gene regulatory networks, protein–protein interaction networks, immune networks, dynamical networks, multiscale networks, hierarchical clustering, modularity, community detection, information theory, Shannon entropy, mutual information, Kullback–Leibler divergence, Jensen–Shannon divergence, complexity theory, algorithmic complexity, Kolmogorov complexity, Turing machines, computational complexity, NP–hard problems, optimisation, convex optimisation, non–convex optimisation, gradient descent, stochastic gradient descent, Adam optimiser, evolutionary algorithms, genetic algorithms, particle swarm optimisation, ant colony optimisation, simulated annealing, Bayesian optimisation, Markov chain Monte Carlo, Gibbs sampling, variational inference, probabilistic programming, causal inference, counterfactual analysis, sensitivity analysis, robustness analysis, uncertainty quantification, error propagation, variance reduction, surrogate modelling, reduced order models, high performance computing, parallel computing, distributed computing, GPU acceleration, CUDA programming, MPI, OpenMP, quantum computing, quantum algorithms, Grover's algorithm, Shor's algorithm, quantum annealing, quantum machine learning, hybrid quantum–classical models, future contingencies, scenario planning, stress testing, resilience modelling, adaptive systems, evolutionary dynamics, co–evolution, arms race, predator–prey models, ecological modelling, fitness landscapes, landscape ruggedness, adaptive peaks, valley crossing, tumour evolution, clonal evolution, immune surveillance, immune escape, therapeutic resistance, evolutionary game theory, replicator dynamics, Nash equilibria, evolutionary stable strategies, cancer ecosystems, tumour ecology, competition, cooperation, parasitism, resource allocation, niche construction, tumour dormancy, relapse mechanisms, latency, minimal residual disease, eradication thresholds, cure probability, survival probability, remission, remission durability, patient stratification, personalised medicine, precision medicine, systems oncology, integrative oncology, translational oncology, computational biomedicine, mathematical medicine, fractal oncology, ψ–Hamzah Equation, Hamzah model, Seyed Rasoul Jalali, ψ–Hamzah multiscale framework, ψ–Hamzah fractional–fractal derivative, ψ–Hamzah complex integration, ψ–Hamzah cancer resistance model, ψ–Hamzah pharmacokinetics, ψ–Hamzah pharmacodynamics, ψ–Hamzah adaptive dosing, ψ–Hamzah entropy analysis, ψ–Hamzah intelligence index, ψ–Hamzah validation, ψ–Hamzah field simulation, ψ–Hamzah therapeutic design, ψ–Hamzah vaccine, ψ–Hamzah drug, ψ–Hamzah intellectual property, ψ–Hamzah universal cure

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

Autoři: Utkina-Sosunova, Irina Chiorazzi, Alessia de Planell-Saguer, Mariangels a další

Zdroj: Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)

Témata: Male, 0301 basic medicine, 0303 health sciences, neurotoxicity, vincristine, neuropathy, CIPN, animal models, in vitro models, translational research, Science, Peripheral Nervous System Diseases, Article, Rats, 3. Good health, Rats, Sprague-Dawley, 03 medical and health sciences, Neuroprotective Agents, Soluble Guanylyl Cyclase, Vincristine, Molsidomine, Medicine, Animals, Humans, Neurotoxicity Syndromes

Popis souboru: application/pdf

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39164364
https://doaj.org/article/becfb928778f4455b47dda2d76d7e062

Poyphenols – between neuroprotection and neurotoxicity

Autoři: Lea POGAČNIK Rui F.M. SILVA

Zdroj: Acta Agriculturae Slovenica, Vol 115, Iss 2, Pp 377-387 (2020)

Témata: polyphenols, neuroprotection, nevrotoxicity, bioavailability, models in vitro, Agriculture

Popis souboru: electronic resource

Relation: https://journals.uni-lj.si/aas/article/view/12946; https://doaj.org/toc/1854-1941

Přístupová URL adresa: https://doaj.org/article/3b7c0b8cd4e442f4b83cddbbbf794553

Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges

Autoři: Yaqing Wang Peng Wang Jianhua Qin

Zdroj: Advanced Science, Vol 9, Iss 10, Pp n/a-n/a (2022)

Témata: coronavirus disease 2019, human models in vitro, organoids, organs‐on‐chips, severe acute respiratory syndrome coronavirus 2, Science

Popis souboru: electronic resource

Relation: https://doaj.org/toc/2198-3844

Přístupová URL adresa: https://doaj.org/article/6bc9eac96db5479e970d83d41dde1643

THE ANTIOXIDANT CHARACTERISTICS OF SOME NATURAL BIOFLAVANOIDS

Autoři: Литвиненко , В. I. Ходаков, I. В.

Zdroj: Odesa National University Herald. Biology; Vol. 15 No. 6 (2010); 15-21
Вестник Одесского национального университета. Биология; Том 15 № 6 (2010); 15-21
Вісник Одеського національного університету. Біологія; Том 15 № 6 (2010); 15-21

Témata: модели in vitro, моделі in vitro, models in vitro, bioflavanoids, antioxidant activity, антиоксидантная активность, біофлаваноїди, антиоксидантна активність, биофлаваноиды

Popis souboru: application/pdf

Přístupová URL adresa: http://visbio.onu.edu.ua/article/view/258629

THE ANTIOXIDANT CHARACTERISTICS OF SOME NATURAL BIOFLAVANOIDS ; АНТИОКСИДАНТНЫЕ СВОЙСТВА НЕКОТОРЫХ ПРИРОДНЫХ БИОФААВАНОИДОВ ; АНТИОКСИДАНТНІ ВЛАСТИВОСТІ ДЕЯКИХ ПРИРОДНИХ БІОФЛАВАНОЇДІВ

Autoři: Макаренко, О. А. Левицький, А. П. Литвиненко , В. I. a další

Zdroj: Odesa National University Herald. Biology; Vol. 15 No. 6 (2010); 15-21 ; Вестник Одесского национального университета. Биология; Том 15 № 6 (2010); 15-21 ; Вісник Одеського національного університету. Біологія; Том 15 № 6 (2010); 15-21 ; 2415-3125 ; 2077-1746

Témata: біофлаваноїди, антиоксидантна активність, моделі in vitro, биофлаваноиды, антиоксидантная активность, модели in vitro, bioflavanoids, antioxidant activity, models in vitro

Popis souboru: application/pdf

Relation: http://visbio.onu.edu.ua/article/view/258629/255388; http://visbio.onu.edu.ua/article/view/258629

Dostupnost: http://visbio.onu.edu.ua/article/view/258629

Chick embryo experimental platform for micrometastases research in a 3d tissue engineering model: Cancer biology, drug development, and nanotechnology applications

Autoři: Guller, A Kuschnerus, I Rozova, V a další

Zdroj: urn:ISSN:2227-9059 ; Biomedicines, 9, 11, 1578

Témata: 3206 Medical Biotechnology, 32 Biomedical and Clinical Sciences, Biotechnology, Breast Cancer, Cancer, Bioengineering, Nanotechnology, Digestive Diseases, Liver Disease, Women's Health, 3D culture, chick embryo, doxorubicin, liver, mesoporous silica nanoparticles, metastasis, micrometastasis, tissue engineering, triple-negative breast cancer, tumor models in vitro, anzsrc-for: 3206 Medical Biotechnology, anzsrc-for: 32 Biomedical and Clinical Sciences, anzsrc-for: 3101 Biochemistry and cell biology, anzsrc-for: 3214 Pharmacology and pharmaceutical sciences, anzsrc-for: 3404 Medicinal and biomolecular chemistry

Popis souboru: application/pdf

Relation: https://hdl.handle.net/1959.4/unsworks_79682; https://doi.org/10.3390/biomedicines9111578

Dostupnost: https://hdl.handle.net/1959.4/unsworks_79682
https://unsworks.unsw.edu.au/bitstreams/3d13a059-ff7d-4525-a3ba-3dc441060593/download
https://doi.org/10.3390/biomedicines9111578

Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models

Autoři: Hoare, Owen Fraunhoffer, Nicolas Elkaoutari, Abdessamad a další

Přispěvatelé: Hoare, Owen Fraunhoffer, Nicolas Elkaoutari, Abdessamad a další

Zdroj: ISSN: 2072-6694.

Témata: in vitro models, in vivo models, personalized medicine, chemosensitivity prediction, pancreatic cancer, pancreatic cancer chemosensitivity prediction personalized medicine in vivo models in vitro models, [SDV]Life Sciences [q-bio]

Dostupnost: https://hal.science/hal-04210691
https://hal.science/hal-04210691v1/document
https://hal.science/hal-04210691v1/file/cancers-13-02473.pdf
https://doi.org/10.3390/cancers13102473

The applicability of in vitro models of the intestinal barrier for the risk assessment of engineered nanomaterials used as food additives

Autoři: Garcia Rodriguez, Alba Marcos Dauder, Ricardo Cortes Crignola, Constanza a další

Přispěvatelé: Garcia Rodriguez, Alba Marcos Dauder, Ricardo Cortes Crignola, Constanza a další

Zdroj: TDX (Tesis Doctorals en Xarxa)

Témata: Nanotoxicologia, Nanotoxicología, Nanotoxicology, Barrera intestinal, Intestinal barrier, Models in vitro, Modelos in vitro, In vitro models, Ciències Experimentals

Time: 575

Popis souboru: 210 p.; application/pdf

Relation: http://hdl.handle.net/10803/669883

Dostupnost: http://hdl.handle.net/10803/669883

Modelos in vitro para previsão de absorção gastrintestinal empregados no desenvolvimento de novos fármacos

Autoři: Galves, Fernanda Rodrigues Dalla Costa, Teresa Cristina Tavares

Přispěvatelé: Galves, Fernanda Rodrigues Dalla Costa, Teresa Cristina Tavares

Témata: Models in vitro, Absorption, Caco-2, PAMPA, TIM, PBPK, Medicamentos : Absorção, Desenvolvimento de fármacos, Farmacocinética

Popis souboru: application/pdf

Relation: http://hdl.handle.net/10183/70138; 000821936

Dostupnost: http://hdl.handle.net/10183/70138

Conditionally Reprogrammed Cells as Preclinical Model for Rare Cancers.

Autoři: Krawczyk E; Department of Pathology, Center for Cell Reprogramming, Georgetown University Medical Center, Washington, DC 20057, USA.

Zdroj: Cancers [Cancers (Basel)] 2025 Aug 29; Vol. 17 (17). Date of Electronic Publication: 2025 Aug 29.

Způsob vydávání: Journal Article; Review

Informace o časopise: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

Autoři: Utkina-Sosunova, I Chiorazzi, A de Planell-Saguer, M a další

Témata: neurotoxicity, vincristine, neuropathy, CIPN, animal models, in vitro models, translational research, BIO/16 - ANATOMIA UMANA, info:eu-repo/semantics/article

URL: https://hdl.handle.net/10281/503139
info:eu-repo/semantics/altIdentifier/pmid/39164364
info:eu-repo/semantics/altIdentifier/wos/WOS:001295308500099
volume:14
issue:1
journal:SCIENTIFIC REPORTS

THE ANTIOXIDANT CHARACTERISTICS OF SOME NATURAL BIOFLAVANOIDS

Zdroj: Odesa National University Herald. Biology; Vol. 15 No. 6 (2010); 15-21; 15-21; 15-21; 2415-3125; 2077-1746

Témata: bioflavanoids, antioxidant activity, models in vitro, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: http://visbio.onu.edu.ua/article/view/258629
http://visbio.onu.edu.ua/article/view/258629/255388
http://visbio.onu.edu.ua/article/view/258629/255388

Chick embryo experimental platform for micrometastases research in a 3d tissue engineering model: Cancer biology, drug development, and nanotechnology applications

Autoři: Guller, A ; https://orcid.org/0000-0002-8866-9838 Kuschnerus, I Rozova, V a další

Zdroj: urn:ISSN:2227-9059; Biomedicines, 9, 11, 1578

Témata: 3206 Medical Biotechnology, 32 Biomedical and Clinical Sciences, Women's Health, Biotechnology, Liver Disease, Digestive Diseases, Cancer, Bioengineering, Nanotechnology, Breast Cancer, 3D culture, chick embryo, doxorubicin, liver, mesoporous silica nanoparticles, metastasis, micrometastasis, tissue engineering, triple-negative breast cancer, tumor models in vitro, anzsrc-for: 3206 Medical Biotechnology, anzsrc-for: 32 Biomedical and Clinical Sciences, anzsrc-for: 3101 Biochemistry and cell biology, anzsrc-for: 3214 Pharmacology and pharmaceutical sciences, anzsrc-for: 3404 Medicinal and biomolecular chemistry, journal article, http://purl.org/coar/resource_type/c_6501

URL: http://hdl.handle.net/1959.4/unsworks_79682
https://unsworks.unsw.edu.au/bitstreams/3d13a059-ff7d-4525-a3ba-3dc441060593/download
https://doi.org/10.3390/biomedicines9111578

[In vitro models of Mycobacterium tuberculosis dormancy, and in vivo models of latent tuberculosis infection.]

Autoři: Fursov MV Dyatlov IA Potapov VD

Zdroj: Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2019; Vol. 64 (5), pp. 299-307.

Způsob vydávání: Journal Article; Review

Informace o časopise: Publisher: Eco-Vector Country of Publication: Russia (Federation) NLM ID: 9432021 Publication Model: Print Cited Medium: Print ISSN: 0869-2084 (Print) Linking ISSN: 08692084 NLM ISO Abbreviation: Klin Lab Diagn

Výrazy ze slovníku MeSH: Latent Tuberculosis* , Mycobacterium tuberculosis* , Tuberculosis*, Animals ; Cells, Cultured ; Disease ; Disease Models, Animal ; Humans